-
3-Hydroxybutyrate (BHBA): Unraveling Ferroptosis Inhibition
2026-07-29
Explore how 3-hydroxybutyrate (BHBA) uniquely modulates ferroptosis and neuronal survival in advanced stroke models. This article reveals new mechanistic insights and protocol guidance for researchers using BHBA as a metabolic and epigenetic tool.
-
BML-277: Chk2 Inhibitor Transforming DNA Damage Response Res
2026-07-29
BML-277 stands out as a potent and selective Chk2 inhibitor, enabling precise dissection of DNA damage response signaling and radioprotection of T-cells. Its robust nanomolar potency and ATP-competitive mechanism empower both fundamental and translational research, particularly in cancer biology and genome stability. Here, we explore applied workflows, troubleshooting guidance, and how new mechanistic insights drive next-generation experimental design.
-
EdU Imaging Kits: Precision DNA Synthesis for Proliferation
2026-07-28
EdU Imaging Kits (HF488) empower researchers to quantify cell proliferation with exceptional sensitivity and workflow speed, leveraging robust click chemistry detection of 5-ethynyl-2'-deoxyuridine incorporation. This article details optimized protocols, advanced applications in oncology, and actionable troubleshooting, drawing uniquely on recent findings in hepatocellular carcinoma biology.
-
SOAT1 Inhibition Restores Lipophagy in PHMG-Induced Lung Fib
2026-07-28
This study identifies sterol O-acyltransferase 1 (SOAT1) as a previously unrecognized driver of foam cell formation and pulmonary fibrosis following polyhexamethylene guanidine (PHMG) exposure. The research demonstrates that SOAT1 inhibition restores lipophagy and disrupts the pathological cascade, holding promise as a targeted intervention in environmentally linked fibrotic lung diseases.
-
Pazopanib (GW-786034): Translational Leverage in Genotype-Dr
2026-07-27
Discover how Pazopanib (GW-786034) empowers genotype-tailored cancer research by exploiting vulnerabilities in tumor signaling. This in-depth article explores mechanistic insights, experimental design, and the latest evidence on ATRX-deficient cancer models.
-
AM251 as a CB1 Receptor Antagonist: Applied Workflows in Res
2026-07-27
AM251 unlocks precise control in cannabinoid receptor research, enabling advanced dissection of neuropharmacology and metabolic pathways. This guide translates bench protocols, troubleshooting, and novel experimental insights for scientists seeking to leverage AM251’s selectivity and potency.
-
Disodium Bicinchoninate: Water-Soluble Reagent for Cardiac A
2026-07-26
Disodium bicinchoninate, a highly water-soluble chelating agent from APExBIO, transforms molecular biology and cardiac fibrosis research by overcoming common solvent incompatibilities and enabling robust, reproducible workflows. Its unique properties support advanced assay design, especially when organic solvent interference is a concern.
-
Palonosetron Hydrochloride: Precision 5-HT3 Receptor Antagon
2026-07-25
Palonosetron hydrochloride sets a new benchmark for 5-HT3 receptor antagonist research, combining nanomolar potency with subtype-selective and prolonged receptor inhibition. This article guides users through practical experimental workflows, troubleshooting, and the unique kinetic insights that empower advanced cancer research and transporter assays.
-
Cy7 NHS Ester for Near-Infrared Protein and Peptide Labeling
2026-07-24
Cy7 NHS ester (SKU A8109) is a sulfonated, hydrophilic near-infrared dye for labeling primary amines in proteins and peptides, solving challenges related to water solubility and minimizing fluorescence quenching. It is best suited for sensitive biomolecule labeling in aqueous environments and in vivo imaging, but is not appropriate for workflows lacking accessible amino groups or requiring long-term storage of dye solutions.
-
Radioiodinated Balsalazide as a Selective UC Radiotracer in
2026-07-24
This study presents the development of [125/131I]balsalazide, a highly selective radiotracer for imaging ulcerative colitis (UC) in mice, achieving high labeling yield and stability. The work addresses key limitations of prior imaging agents by enabling robust biodistribution analysis over 24 hours, supporting improved preclinical models for UC.
-
Macrophage-Derived EV miR-660 Drives Breast Cancer Progressi
2026-07-23
This study uncovers how tumor-associated macrophage (TAM)-derived extracellular vesicle (EV) microRNA-660 (miR-660) enhances breast cancer metastasis by targeting KLHL21 and activating NF-κB p65 signaling. The mechanistic insights clarify a key pathway of tumor microenvironment-driven malignancy and offer a precise model for autophagy modulation and cancer biology research.
-
Assessing Low-Cost Microfluidic Mixers for LNP-mRNA Formulat
2026-07-23
Forrester et al. (2025) systematically evaluated the performance of low-cost microfluidic mixers against traditional pipette mixing in the manufacture of lipid nanoparticles (LNPs) designed for mRNA delivery. The study demonstrates that accessible microfluidic platforms can reliably produce LNPs with properties suitable for high-throughput screening and gene expression studies, broadening access to nanoparticle-based mRNA research.
-
Solving RNA Synthesis Challenges with HyperScribe™ T7 Kit (K
2026-07-22
This article provides a scenario-driven, evidence-backed guide for biomedical researchers and laboratory scientists facing RNA synthesis bottlenecks. Discover how the HyperScribe™ T7 High Yield RNA Synthesis Kit (SKU K1047) streamlines T7 RNA polymerase transcription, delivers high yields, and integrates seamlessly with advanced applications like capped and biotinylated RNA synthesis, RNA vaccine research, and RNA interference experiments.
-
NF 340 in Translational Cancer Research: P2Y11 Antagonist In
2026-07-22
Explore the role of NF 340, a potent P2Y11 antagonist, in advanced cancer biology and immunology research. This article delivers deep analysis of purinergic signaling modulation and highlights how NF 340 uniquely enables functional assays targeting metastatic pathways.
-
Bifendate Inhibits Autophagy and Reduces Lipid Accumulation
2026-07-21
This study uncovers how bifendate (DDB), a clinically used hepatoprotective agent, inhibits autophagy at multiple steps and diminishes oleic acid-induced lipid droplet accumulation in vitro. These insights clarify bifendate's cellular mechanisms and suggest new avenues for targeting hepatic lipid storage disorders.